BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 205 filers reported holding BRIDGEBIO PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $919,736 | -83.9% | 53,473 | -84.4% | 0.00% | -88.0% |
Q1 2023 | $5,699,955 | +433.0% | 343,785 | +144.9% | 0.02% | +316.7% |
Q4 2022 | $1,069,482 | -6.4% | 140,352 | +22.1% | 0.01% | -14.3% |
Q3 2022 | $1,143,000 | +305.3% | 114,955 | +579.1% | 0.01% | +250.0% |
Q4 2021 | $282,000 | -80.9% | 16,928 | -29.4% | 0.00% | -91.3% |
Q1 2021 | $1,477,000 | +523.2% | 23,985 | +279.9% | 0.02% | +666.7% |
Q3 2020 | $237,000 | -45.1% | 6,314 | -52.4% | 0.00% | -50.0% |
Q2 2020 | $432,000 | – | 13,251 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |